- Home
- CNMD
CNMD
CONMED Corporation
as 11-21-2024 11:32am EST
Conmed Corp is a Utica, New York-based medical equipment company that focuses on sports medicine procedures and general surgeries. The firm currently reports through two reporting units, orthopedic surgery, and general surgery. From a geographic perspective, the firm is U.S.-centric, with maximum domestic sales accounting for revenue, EMEA accounting for second place, APAC at third, and the non-U.S. Americas region driving the remaining revenue.
| Founded: | 1970 | Country: | United States |
| Employees: | N/A | City: | LARGO |
| Market Cap: | 2.2B | IPO Year: | 1987 |
| Target Price: | $82.83 | AVG Volume (30 days): | 455.2K |
| Analyst Decision: | Buy | Number of Analysts: | 6 |
| Dividend Yield: | Dividend Payout Frequency: | Quarterly | |
| EPS: | 4.22 | EPS Growth: | 127.53 |
| 52 Week Low/High: | $61.05 - $117.27 | Next Earning Date: | 10-30-2024 |
| Revenue: | $1,288,116,000 | Revenue Growth: | 10.23% |
| Revenue Growth (this year): | 6.69% | Revenue Growth (next year): | 7.45% |
Latest CONMED Corporation News
CNMD Breaking Stock News: Dive into CNMD Ticker-Specific Updates for Smart Investing
Business Wire
3 days ago
CONMED Corporation to Participate in a Fireside Chat at the Piper Sandler Healthcare Conference
Zacks
6 days ago
Conmed (CNMD) is a Top-Ranked Momentum Stock: Should You Buy?
Argus Research
9 days ago
CNMD: Raising target price to $79.00
Zacks
10 days ago
Why Conmed (CNMD) is a Top Value Stock for the Long-Term
Zacks
13 days ago
Here's Why Conmed (CNMD) is a Strong Growth Stock
Argus Research
16 days ago
CNMD: Raising target price to $78.00
Business Wire
17 days ago
CONMED Corporation to Participate in Fireside Chats at Two Investor Conferences on November 19-20
Simply Wall St.
19 days ago
Results: CONMED Corporation Exceeded Expectations And The Consensus Has Updated Its Estimates
Compare CNMD vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "CNMD CONMED Corporation - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.